JP2022514241A5 - - Google Patents

Info

Publication number
JP2022514241A5
JP2022514241A5 JP2021533856A JP2021533856A JP2022514241A5 JP 2022514241 A5 JP2022514241 A5 JP 2022514241A5 JP 2021533856 A JP2021533856 A JP 2021533856A JP 2021533856 A JP2021533856 A JP 2021533856A JP 2022514241 A5 JP2022514241 A5 JP 2022514241A5
Authority
JP
Japan
Prior art keywords
compound according
aaa
group
compound
methyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2021533856A
Other languages
English (en)
Japanese (ja)
Other versions
JP7606966B2 (ja
JP2022514241A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2019/062284 external-priority patent/WO2020131283A1/en
Publication of JP2022514241A publication Critical patent/JP2022514241A/ja
Publication of JP2022514241A5 publication Critical patent/JP2022514241A5/ja
Application granted granted Critical
Publication of JP7606966B2 publication Critical patent/JP7606966B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2021533856A 2018-12-18 2019-11-19 ミトコンドリア病を標的とするアナログ Active JP7606966B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862781156P 2018-12-18 2018-12-18
US62/781,156 2018-12-18
PCT/US2019/062284 WO2020131283A1 (en) 2018-12-18 2019-11-19 Analogs that target mitochondrial diseases

Publications (3)

Publication Number Publication Date
JP2022514241A JP2022514241A (ja) 2022-02-10
JP2022514241A5 true JP2022514241A5 (cg-RX-API-DMAC7.html) 2022-11-21
JP7606966B2 JP7606966B2 (ja) 2024-12-26

Family

ID=71101584

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2021533856A Active JP7606966B2 (ja) 2018-12-18 2019-11-19 ミトコンドリア病を標的とするアナログ

Country Status (9)

Country Link
US (2) US12252554B2 (cg-RX-API-DMAC7.html)
EP (1) EP3898653A4 (cg-RX-API-DMAC7.html)
JP (1) JP7606966B2 (cg-RX-API-DMAC7.html)
KR (1) KR102995415B1 (cg-RX-API-DMAC7.html)
CN (1) CN113383005A (cg-RX-API-DMAC7.html)
AU (1) AU2019401254B2 (cg-RX-API-DMAC7.html)
CA (1) CA3123610A1 (cg-RX-API-DMAC7.html)
IL (1) IL284014A (cg-RX-API-DMAC7.html)
WO (1) WO2020131283A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases
US20240197623A1 (en) * 2021-04-07 2024-06-20 Stealth Bio Therapeutics Inc. Silica-based formulations of therapeutic oliogpeptides and peptidomimetics
KR102876070B1 (ko) * 2023-02-08 2025-10-24 웰펩 주식회사 신규 펩티도미메틱을 유효성분으로 포함하는 아토피 피부염의 예방 또는 치료용 조성물
WO2026151834A1 (en) 2025-01-09 2026-07-16 Stealth Biotherapeutics Inc. Compounds for use in medical management of subjects with muscular dystrophy
WO2026151846A1 (en) 2025-01-09 2026-07-16 Stealth Biotherapeutics Inc. Compositions for use in the treatment of heart failure, idiopathic cardiomyopathy, dilated cardiomyopathy, restrictive cardiomyopathy, hypertrophic cardiomyopathy, or hypertensive cardiomyopathy

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI2656854T1 (sl) 2003-02-04 2015-09-30 Cornell Research Foundation, Inc. Uporabe aromatsko-kationskega peptida
CA2787331A1 (en) * 2010-01-25 2011-07-28 Hazel H. Szeto Aromatic-cationic peptides and uses of same
EP2808029A3 (en) 2010-03-15 2015-04-01 Stealth Peptides International, Inc. Combination therapies using cyclosporine and aromatic cationic peptides
CN103249423A (zh) 2010-07-09 2013-08-14 康肽德生物医药技术有限公司 预防或治疗缺血/再灌注损伤之后无复流的方法
US8383919B2 (en) 2010-12-14 2013-02-26 Xueyun Gao Highly fluorescent peptide-metallic nanoclusters as bio-probes and methods of synthesis thereof
EP3108975A1 (en) 2011-03-24 2016-12-28 Cornell University Aromatic-cationic peptides and uses of same
CA2865409C (en) 2012-02-23 2020-07-21 Cornell University Aromatic-cationic peptides and uses of same
EP3626252A1 (en) 2013-03-01 2020-03-25 Stealth Biotherapeutics Corp Methods and compositions for the prevention or treatment of barth syndrome
CA2916492A1 (en) 2013-06-27 2014-12-31 Stealth Biotherapeutics Corp Peptide therapeutics and methods for using same
CN106459169A (zh) 2014-03-03 2017-02-22 康德生物医疗技术公司 药学上相关的芳香族阳离子肽
WO2015183984A2 (en) 2014-05-28 2015-12-03 Stealth Peptides International, Inc. Therapeutic compositions including tocopherol and uses thereof
WO2016144352A2 (en) 2015-03-11 2016-09-15 Stealth Peptides International, Inc. Therapeutic compositions including acrylamido compounds or phenyl-substituted maleimide compounds, variants thereof and methods of using the same
WO2017093897A1 (en) 2015-11-30 2017-06-08 Peter Schiller Aromatic-cationic peptides conjugated to antioxidants and their use in treating complex regional pain syndrome
CA3010321A1 (en) 2015-12-31 2017-07-06 Scott Duncan Therapeutic compositions including peptides and uses thereof
US10870678B2 (en) 2016-04-11 2020-12-22 Arcuate Therapeutics, Inc. Chiral peptides
US20190276494A1 (en) 2016-05-19 2019-09-12 Stealth Biotherapeutics Corp. Compositions and methods for the prevention and treatment of mitochondrial myopathies
WO2018186404A1 (ja) * 2017-04-03 2018-10-11 出光興産株式会社 有機エレクトロルミネッセンス素子及び電子機器
WO2018223032A1 (en) 2017-06-02 2018-12-06 Stealth Biotherapeutics Corp. Crystalline salt forms of sbt-20
US20200361987A1 (en) 2017-11-15 2020-11-19 Stealth Biotherapeutics Corp. Deuterated tetrapeptides that target mitochondria
CN113544138B (zh) 2018-12-18 2024-10-29 隐形生物治疗公司 线粒体靶向肽
WO2020131283A1 (en) 2018-12-18 2020-06-25 Stealth Biotherapeutics Corp. Analogs that target mitochondrial diseases

Similar Documents

Publication Publication Date Title
JP2022511939A5 (cg-RX-API-DMAC7.html)
JP2021191784A5 (cg-RX-API-DMAC7.html)
JP2005523922A5 (cg-RX-API-DMAC7.html)
JP2016515561A5 (cg-RX-API-DMAC7.html)
JP2008510691A5 (cg-RX-API-DMAC7.html)
JP2020531422A5 (cg-RX-API-DMAC7.html)
JP2016534063A5 (cg-RX-API-DMAC7.html)
JP2020504733A5 (cg-RX-API-DMAC7.html)
JP2016518437A5 (cg-RX-API-DMAC7.html)
JP2017537940A5 (cg-RX-API-DMAC7.html)
JP2016531126A5 (cg-RX-API-DMAC7.html)
JP2015508103A5 (cg-RX-API-DMAC7.html)
JP2018535967A5 (cg-RX-API-DMAC7.html)
JP2018518518A5 (cg-RX-API-DMAC7.html)
JP2019500387A5 (cg-RX-API-DMAC7.html)
JP2010500962A5 (cg-RX-API-DMAC7.html)
JP2017105793A5 (cg-RX-API-DMAC7.html)
JP2006514012A5 (cg-RX-API-DMAC7.html)
JP2017523225A5 (cg-RX-API-DMAC7.html)
JP2007504235A5 (cg-RX-API-DMAC7.html)
JP2020500182A5 (cg-RX-API-DMAC7.html)
JP2007502295A5 (cg-RX-API-DMAC7.html)
JP2019527724A5 (cg-RX-API-DMAC7.html)
JP2014500265A5 (cg-RX-API-DMAC7.html)
JP2019535723A5 (cg-RX-API-DMAC7.html)